89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Inclusion Criteria: * Patient age \> 25 years old and \< 80 years old * Patients with reoccurrence of brain tumor * The principal investigator or co-PI must review MRI and CT findings based on the radiologic assessment provided they meet the following imaging criteria (as established in the clinical trial 09-177): OR * Patients with newly diagnosed GBM and one of the following options: * Eligible for surgery after the last research scan. * Significant residual disease after initial surgery * The principal investigator or co-PI must review MRI and CT findings and agree with the presence of significant residual disease * Treatment (non-surgical) naïve * Karnofsky Performance Score ≥ 70 Exclusion Criteria: * Laboratory values: * Serum creatinine \>2.5 mg/dL. * AST (SGOT) \>2.5x ULN. * Bilirubin (total) \>1.5x ULN. * Serum calcium \>11 mg/dL. * Pregnant or breastfeeding (if a female is of childbearing potential, and unsure of pregnancy status, a standard pregnancy test should be done). * If an initial biopsy demonstrates neoplasm other than GBM * Presence of any other co-existing condition which, in the judgment of the investigator, might increase the risk to the subject. * Presence of serious systemic illness, including: uncontrolled inter-current infection, uncontrolled malignancy, significant renal disease, or psychiatric/social situations, which might limit compliance with study requirements * Prior treatment. * Other serious illness (es), which might preclude completion of this, study or interfere with determination of causality of any adverse effects experienced in this study.